15 Matching Annotations
  1. Last 7 days
    1. 9

      Case#: Patient 9 (see Table 1), 5 years old - deceased (age at report), 1 year old (age at onset), female, height of 102 cm, weight of 18 kg, located at Mahdia: Touristic region.

      DiseaseAssertion: MPS1 - severe

      FamilyInfo: Parents were 1st cousins (see Table 2), aged 50 yrs (M) and 62 yrs (F).

      CasePresentingHPOs: HP:0004322, HP:0010864, HP:0001537, HP:0000687, HP:0030812, HP:0001999, HP:0007957, HP:0000943 (Short stature, severe intellectual disability, umbilical hernia, widely spaced teeth, enlarged tonsils, facial dysmorphia, corneal clouding, dysostosis multiplex)

      CaseHPOFreeText: Pigmented skin

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CaseEnzymeAssay: IDUA activity 0.020 μKat/kg

      CaseUrineGAGs: N/A

      CaseERT: N/A

      CaseBMT: N/A

      Variant1: c.1882C>T (p.R628X)

      Variant1ClinVarID: 550421

      Variant1CAID: CA2802462

      Variant2: c.1882C>T (p.R628X)

      Variant2ClinVarID: 550421

      Variant2CAID: CA2802462

      AdditionalVariants: N/A

      ParentalGenotype: N/A

      PreviouslyPublished N/A

    1. R628X/R628X6 (1.6%)

      Case#: Severe MPS1 patients, 6 individuals with this genotype

      DiseaseAssertion: Severe MPS I

      FamilyInfo: n/a

      CasePresentingHPOs:

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: n/a

      GenotypingMethod: n/a

      PreviouslyPublished: possible

      Variant: R628X/R628X

      ClinVar: 550421

      CAID: CA2802462

      SupplementalData: Table S1 also lists this variant one time in compound heterozygosity with Q70X

    2. R628X/R628X6 (1.6%)

      Case#: Severe MPS1 patients, 6 individuals with this genotype

      DiseaseAssertion: Severe MPS I

      FamilyInfo: n/a

      CasePresentingHPOs:

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: n/a

      GenotypingMethod: n/a

      PreviouslyPublished: possible

      Variant: R628X/R628X

      ClinVar: 550421

      CAID: CA2802462

      SupplementalData: Table S1 also lists this variant one time in compound heterozygosity with Q70X

    1. 2.1.14 year/MDistended abdomen, developmental delayNo − PathogenicIDUAc.1882C > Tp. Arg628TerHomMPS I

      Case#: Patient 2.1.1, male, 4yo, Indian

      DiseaseAssertion: MPS1

      FamilyInfo: No family history reported, but said not to be consanguineous

      CasePresentingHPOs:

      CaseHPOFreeText: Distended abdomen, developmental delay

      CaseNotHPOs:

      CaseNotHPOFreeText:

      GenotypingMethod: NGS, Sanger

      PreviouslyPublished:

      Variant: c.1882C > T p. Arg628Ter homozygous

      ClinVar: 550421

      CAID: CA2802462

      SupplementalData: n/a

    2. 2.1.14 year/MDistended abdomen, developmental delayNo − PathogenicIDUAc.1882C > Tp. Arg628TerHomMPS I

      Case#: Patient 2.1.1, male, 4yo, Indian

      DiseaseAssertion: MPS1

      FamilyInfo: No family history reported, but said not to be consanguineous

      CasePresentingHPOs:

      CaseHPOFreeText: Distended abdomen, developmental delay

      CaseNotHPOs:

      CaseNotHPOFreeText:

      GenotypingMethod: NGS, Sanger

      PreviouslyPublished:

      Variant: c.1882C > T p. Arg628Ter homozygous

      ClinVar: 550421

      CAID: CA2802462

      SupplementalData: n/a

    1. In this study we report the first development of a denaturating high performance liquid chromatography (dHPLC) protocol for the rapid and accurate detection of recently described mutations in the IDUA gene. Optimal PCR running and dHPLC partial denaturing conditions for mutation detection were established for each PCR amplicon corresponding to 14 IDUA exons and their adjacent intronic/flanking sequences. Results: A total of 12 different mutations, 5 nonsense, 4 missense, 1 deletion, and 2 splice site (intron), in 10 MPS I patients were screened. All mutations revealed a distinct dHPLC pattern thus enabling their accurate detection.

      This proband was "described and recently published by Vazna et al." (PMID: 19396826). Patient is compound heterozygous for c.1882C>T (p.Arg628Ter) and c.208C>T (p.Gln70Ter) (P based on classification by the ClinGen Lysosomal Diseases VCEP); phase confirmed in trans. PM3=0 points

    2. In this study we report the first development of a denaturating high performance liquid chromatography (dHPLC) protocol for the rapid and accurate detection of recently described mutations in the IDUA gene. Optimal PCR running and dHPLC partial denaturing conditions for mutation detection were established for each PCR amplicon corresponding to 14 IDUA exons and their adjacent intronic/flanking sequences. Results: A total of 12 different mutations, 5 nonsense, 4 missense, 1 deletion, and 2 splice site (intron), in 10 MPS I patients were screened. All mutations revealed a distinct dHPLC pattern thus enabling their accurate detection.

      This proband was "described and recently published by Vazna et al." (PMID: 19396826). Patient is compound heterozygous for c.1882C>T (p.Arg628Ter) and c.208C>T (p.Gln70Ter) (P based on classification by the ClinGen Lysosomal Diseases VCEP); phase confirmed in trans. PM3=0 points